Polyclonal Rabbit anti‑Human DDO / D‑Aspartate Oxidase Antibody (Cy3, aa170‑304, WB) LS‑C705119
Polyclonal Rabbit anti‑Human DDO / D‑Aspartate Oxidase Antibody (Cy3, aa170‑304, WB) LS‑C705119
Antibody:
DDO / D-Aspartate Oxidase Rabbit anti-Human Polyclonal (aa170-304) (Cy3) Antibody
Overview
Antibody:
DDO / D-Aspartate Oxidase Rabbit anti-Human Polyclonal (aa170-304) (Cy3) Antibody
Specifications
Description
D-Aspartate Oxidase antibody LS-C705119 is a Cy3-conjugated rabbit polyclonal antibody to human D-Aspartate Oxidase (DDO) (aa170-304). Validated for WB.
Target
Human DDO / D-Aspartate Oxidase
Synonyms
DDO | DDO-1 | DDO-2 | D-aspartate oxidase | D-aspartate oxidase, DDO | Aspartic oxidase | DASOX
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant DDO (Glu170-Gly304) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against DDO.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About DDO / D-Aspartate Oxidase
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, Western blot
Species:
Human, Mouse, Rat
Applications:
Western blot
Reactivity:
Human
Range:
0.156-10 ng/ml
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Reactivity:
Human
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 10/19/2024